MedTrace Logo

Efficacy of Trace Elements in the Treatment of Endometriosis: a Pilot Study

NCT02437175 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2022-03-22

No results posted yet for this study

Summary

The primary objective of this pilot study is to evaluate the efficacy of trace elements, versus placebo, on the reduction of pain in endometriosis of an American Fertility Society (AFSr) score of 2 to 4, combined or not to an adenomyosis, during a chronic treatment of 4 months.

Conditions

  • Endometriosis

Interventions

DIETARY_SUPPLEMENT

ENDO 1/ENDO 2

NUTRI ENDO 1 (1 sequence of 10 tablets on the morning) and NUTRI ENDO 2 ( sequence of 10 tablets at the evening), daily, during 120 days.

DIETARY_SUPPLEMENT

Placebo

Placebo: 1 sequence of 10 tablets on the morning and 1 sequence of 10 tablets at the evening, daily, during 120 days.

Sponsors & Collaborators

  • Expert Clinical Services Organization (ECSOR)

    collaborator UNKNOWN

  • Laboratoires Pronutri

    lead INDUSTRY

Principal Investigators

  • Didier Oberweis, MD · CHU Vésale

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-28
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02437175 on ClinicalTrials.gov